跳至主要内容
临床试验/CTRI/2021/11/038213
CTRI/2021/11/038213尚未招募3 期

A randomised placebo controlled trial to study the impact of probiotic supplementation on behavioural and gastro-intestinal symptoms in children aged 2-9 years with autism spectrum disorder from Delhi NCR clinics

utri Newron Pediatrix Private limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All children between the ages of 2-9 years with autism spectrum disorder diagnosed with DSM 5 criteria
  • All parents who have willingly given an informed written consent

排除标准

  • Brian abnormalities detected by neurological imaging procedures
  • Neurological syndromes or focal neurological signs
  • history of documented sequelae of birth asphyxia or preterm less than 28 weeks gestational age or perinatal injury
  • epilepsy -past or current
  • significant sensory impairments like deafness/blindness
  • use of antibiotics within 2 months prior to enrolment
  • Chronic medical conditions Eg Diabetes, weight and height less than 3rd centile for age, long term use of anti inflammatory use within 2 months prior to enrolment
  • Organic GI disorders like Gastro-esophageal reflux, inflammatory bowel disease or prior bowel surgery

研究者

发起方
utri Newron Pediatrix Private limited

相似试验